Lindsay McAlpine is a Neurology physician affiliated with Yale University. OpenAlex indexes 32 publications with 1,342 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
20 York Street
Ynhh, P.O. Box 20802
New Haven, CT 06520
Telephone
203-785-4085Provider last certified this registry record 29 Jun 2021.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- EMD Serono, Inc.Program year20252 payments
- Celgene CorporationProgram year20231 payment
- GENZYME CORPORATIONProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
75.8%Gabapentinoids46.4%Gabapentin75%Pregabalin25%Part D<11 patientsCalcitonin Gene-related Peptide Receptor Antagonist10.5%Nurtec Odt100%Part D<11 patients+ 2 more classes in this area
Musculoskeletal
24.2%gamma-Aminobutyric Acid-ergic Agonist14.4%Baclofen100%Part D<11 patientsNonsteroidal Anti-inflammatory Drug9.8%Nabumetone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Magnetic Resonance Imaging Biomarkers of Post-COVID-19 Cerebral Microvascular Dysfunction
Yale University
FY2026$231,522K23NS133488 - Magnetic Resonance Imaging Biomarkers of Post-COVID-19 Cerebral Microvascular Dysfunction
Yale University
FY2025$231,525K23NS133488 - Magnetic Resonance Imaging Biomarkers of Post-COVID-19 Cerebral Microvascular Dysfunction
Yale University
FY2024$231,524K23NS133488
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cerebrospinal Fluid Immune Cell Alterations in Women With Neuropsychiatric Long COVID
The Journal of Infectious Diseases
2025 - Long <scp>COVID</scp> in People With Multiple Sclerosis and Related Disorders: A Multicenter Cross‐Sectional Study
Annals of Clinical and Translational Neurology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
John Krystal, MD
Yale University
Lajos Pusztai, MD
Yale University
Lee Schwamm, MD
Yale University
Thomas McGlashan, MD
Yale University
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”